2024-11-17 05:52:26
Ark Biopharmaceutical and Calibr, a Division of  Scripps Research, Announce Co-development Collaboration on AK0705, a Potential First-in-Class Drug for Treating a Broad Spectrum of Respiratory Diseases, Including COPD
Health/ 2023-07-22
Ark Biopharmaceutical and Calibr, a Divi...

Ark Biopharmaceutical will lead development activities for AK0705 with the goal of initiating clinical studies in 2024.

Everest Medicines to Announce Full-Year 2022 Financial Results on March 31, 2023
Corporate/ 2023-07-24
Everest Medicines to Announce Full-Year ...

SHANGHAI,March 15,2023-- Everest Medicines (HKEX 1952.HK),a biopharmaceutical company focused on the development,manufacturing and commercia...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release